BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression

  June 6, 2025

   · 

  3 min read
• 

  Editorial

  Desperate Times, Desperate Measures? RFK’s Vaccine Campaign Only Breeds More Distrust

  Vaccine skepticism is at an all-time high in the U.S., and HHS Secretary Robert F. Kennedy Jr. is making some drastic moves in the name of reversing that trend. But misinformation and inconsistencies within the country’s healthcare agencies highlight problems with his approach.

  June 6, 2025

   · 

  8 min read

   · 

  Jef Akst
• 

  ALS

  Corcept Claims Survival Benefit in ALS Despite Missed Endpoint

  Analysts at Truist Securities called the mid-stage data a “mixed bag,” also flagging gastrointestinal adverse events. However, the readout is unlikely to be “incremental” to Corcept’s overall stock narrative.

  June 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  RFK Jr. Joins Deputies in Voicing Support for Regulatory Flexibility for Cell and Gene Therapies

  In a roundtable event on Thursday, HHS Secretary Robert F. Kennedy Jr. said his office will work to eliminate barriers that keep cell and gene therapies from the market.

  June 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IgA nephropathy

  Otsuka Sees ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial

  Otsuka’s investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with immunoglobulin A nephropathy.

  June 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  GLP-1

  EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide

  Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include the “very rare” risk of non-arteritic anterior ischemic optic neuropathy.

  June 6, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Radiopharmaceuticals

  Perspective Therapeutics Brings Energy to the Radiopharma World

  The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.

  June 6, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• Press Releases

  PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value

  June 6, 2025

   · 

  5 min read
• Press Releases

  Neural’s Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025

  June 6, 2025

   · 

  5 min read
• Press Releases

  Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio

  - Robert Infarinato named VP, Strategic Development - Lisa Carson named as new VP, Finance and Administration

  June 6, 2025

   · 

  5 min read